NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors
NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors
Active, not recruiting · NCT05354323 · Registry updated 2025-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors | Solid Tumors, Adult | Active, not recruiting | Phase 1 | 2025-06-26 | NCT05354323 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NEC OncoImmunity AS | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kaunas University Hospital | Kaunas | Lithuania | 1 |
| National Cancer Institute | Vilnius | Lithuania | 1 |
| Vilnius University Hospital Santaros Clinics | Vilnius | Lithuania | 1 |